TITLE

The Natural History of Portal Hypertensive Gastropathy in Patients with Liver Cirrhosis and Mild Portal Hypertension

AUTHOR(S)
Merli, Manuela; Nicolini, Giorgia; Angeloni, Stefania; Gentili, Federica; Attili, Adolfo Francesco; Riggio, Oliviero
PUB. DATE
October 2004
SOURCE
American Journal of Gastroenterology;Oct2004, Vol. 99 Issue 10, p1959
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
BACKGROUND: Portal hypertensive gastropathy is a potential cause of bleeding in patients with liver cirrhosis. Studies on its natural history have often included patients submitted to endoscopic or pharmacological treatment for portal hypertension.PATIENTS AND METHODS: A total of 222 cirrhotic patients with mild degree of portal hypertension (i.e., with no or small varices at entry, without previous gastrointestinal bleeding and medical, endoscopic, or angiographic treatment) were followed up with upper endoscopy every 12 months for 47± 28 months.RESULTS: Upon enrollment 48 patients presented portal hypertensive gastropathy (43 mild and 5 severe) and the presence of esophageal varices was the only independent predictor of the presence of this gastric lesion at multivariate analysis. The incidence of portal hypertensive gastropathy was 3.0% (1.1–4.9%) at 1 yr and 24% (18.1–29.9%) at 3 yr, while the progression was 3% (1–6.9%) at 1 yr and 14% (4.2–23.8%) at 3 yr. The presence of esophageal varices and the Child-Pugh class B or C at enrollment were predictive of the incidence of portal hypertensive gastropathy, while only Child-Pugh class B or C was correlated with the progression from mild to severe, at multivariate analysis. During follow-up 16 patients bled from portal hypertensive gastropathy (9 acutely and 7 chronically) and one patient died of exsanguination from this lesion.CONCLUSIONS: The natural history of portal hypertensive gastropathy is significantly influenced by the severity of liver disease and severity of portal hypertension. Acute bleeding from portal hypertensive gastropathy is infrequent but may be severe.
ACCESSION #
14816487

 

Related Articles

  • SPLENIC VENOGRAPHY IN PORTAL CIRRHOSIS OF THE LIVER. Konar, N. R.; Chaudhury, D. C. Roy // American Journal of Gastroenterology;Apr1956, Vol. 25 Issue 4, p363 

    Investigates the potential use of splenic venography in the diagnosis of portal cirrhosis of the liver by researchers from Calcutta, India. Usefulness of the procedure in differentiating intrahepatic and extrahepatic block; Safety and tolerability; Sensitivity and accuracy.

  • Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Francesco Salerno // Postgraduate Medical Journal;Dec2008, Vol. 84 Issue 998, p662 

    Hepatorenal syndrome (HRS) is a serious complication of end-stage liver disease, occurring mainly in patients with advanced cirrhosis and ascites, who have marked circulatory dysfunction,1as well as in patients with acute liver failure.2In spite of its functional nature, HRS is associated with a...

  • Pronóstico de pacientes con diagnóstico de carcinoma hepatocelular (CHC) en un hospital de máximo nivel de atención. Santa, Catalina; Ortiz, Margarita María; Hoyos, Sergio; Guzmán, Carlos; Mena, Alvaro; Zuleta, John Jairo; Osorio, Germán; Castrillón, Germán; Navas, María Cristina; Correa, Gonzalo; Restrepo, Juan Carlos // Revista Colombiana de Gastroenterología;Apr2009, Vol. 24 Issue 2, p128 

    Introduction. Hepatocellular carcinoma (HCC) shortens survival significantly due to its usual late diagnosis. Objectives. Describe retrospectively the survival, clinical and biochemical characteristics in patients with a diagnosis of HCC. Patients and Methods. A retrospective study which...

  • Portal hypertension. Berzigotti, Annalisa // Hot Topics in Viral Hepatitis;2011, Vol. 7 Issue 21, p17 

    Portal hypertension is a frequent and severe clinical syndrome, which almost invariably complicates liver cirrhosis, and is responsible for its clinical consequences, such as gastroesophageal varices, ascites, hepatorenal syndrome, hepatic encephalopathy, bacteremia, and hypersplenism. In recent...

  • Beyond "Cirrhosis.". Hytiroglou, Prodromos; Snover, Dale C.; Alves, Venancio; Balabaud, Charles; Bhathal, Prithi S.; Bioulac-Sage, Paulette; Crawford, James M.; Dhillon, Amar P.; Ferrell, Linda; Guido, Maria; Nakanuma, Yasuni; Paradis, Valerie; Quaglia, Alberto; Theise, Neil D.; Thung, Swan N.; Tsui, Wilson M. S.; van Leeuwen, Dirk J. // American Journal of Clinical Pathology;Jan2012, Vol. 137 Issue 1, p5 

    "Cirrhosis" is a morphologic term that has been used for almost 200 years to denote the end stage of a variety of chronic liver diseases. The term implies a condition with adverse prognosis due to the well-known complications of portal hypertension, hepatocellular carcinoma, and liver failure....

  • Clinicopathological Study of Alcoholic Fibrosis. Takada, Akira; Nei, Jinichi; Matsuda, Yoshiro; Kanayama, Ryuichi // American Journal of Gastroenterology;Sep1982, Vol. 77 Issue 9, p660 

    Among 112 patients with alcoholic liver injury, 45 had alcoholic fibrosis. The incidence of alcoholic fibrosis was 40.2% which was the highest among various types of alcoholic liver injury (fatty liver: 3.6%. alcoholic hepatitis; 2.7% and liver cirrhosis; 31.3%). Clinical features of alcoholic...

  • β-BLOCKERS IN PORTAL HYPERTENSION: VARIATION ON A THEME. Brady III., Charles E.; Johnson, David A.; Cattau Jr., Edward L. // American Journal of Gastroenterology;Jul1992, Vol. 87 Issue 7, p921 

    Comments on a study that examined the efficacy of propranolol in preventing rebleeding from severe portal hypertensive gastropathy in cirrhotics. Information on portal hypertensive gastropathy; Overview of the study; Difference between propranolol and nonpropranolol-treated patients.

  • Transjugular intrahepatic portosystemic shunt in Vienna -- A decade later. Angermayr, Bernhard; Cejna, Manfred; Karnel, Franz; Gschwantler, Michael; König, Franz; Pidlich, Johann; Mendel, Helmuth; Brunner, Harald; Pichler, Ludwig; Ferenci, Peter; Lammer, Johannes; Gangl, Alfred; Peck-Radosavljevic, Markus // Wiener Klinische Wochenschrift;2004, Vol. 116 Issue 17/18, p608 

    Implantation of a transjugular intrahepatic portosystemic shunt (TIPS) for therapy of portal hypertension has been available in Vienna, Austria, since 1991. Ten years of experience with this technique led the Vienna TIPS Study Group to retrospectively analyse characteristics and outcome of all...

  • Ethics in Gastroenterology: Case Discussions. Shapiro, Robyn; Vakil, Nimish // American Journal of Gastroenterology;Mar2004, Vol. 99 Issue 3, p408 

    Comments on a clinical case of a 50-year-old man diagnosed with end-stage liver disease caused by chronic alcohol use. Evidence of portal hypertension on the patient; Refusal of the patient to undergo transplantation; Key ethical principle of the case; Conflict among the patient's sisters in...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics